Categories AlphaGraphs, Earnings, Health Care
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue.
Net income attributable to shareholders was $72 million or $0.04 per share in the December quarter, compared to $1.76 billion or $0.87 per share in the comparable period of 2023. Adjusted profit dropped to $1.67 per share in Q4 from $1.70 per share in the prior year period.
Fourth-quarter revenues increased 8% from last year to $12.3 billion. Domestic revenues rose 9% and international revenues moved up 5%.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Here’s why Dollar General (DG) is well-positioned for meaningful growth ahead
Shares of Dollar General Corporation (NYSE: DG) rose over 6% on Friday. The stock has gained 76% year-to-date. The discount store chain delivered robust results for the third quarter of
Docusign (DOCU) Earnings: 3Q26 Key Numbers
Docusign, Inc. (NASDAQ: DOCU) reported its earnings results for the third quarter of 2026. Revenue increased 8% year-over-year to $818.4 million. GAAP net income was $83.7 million, or $0.40
Infographic: How Ulta Beauty (ULTA) performed in Q3 2025
Ulta Beauty, Inc. (NASDAQ: ULTA) reported its earnings results for the third quarter of 2025. Net sales increased 12.9% year-over-year to $2.9 billion, driven by comparable sales growth, the Space
